Literature DB >> 18666327

Resting energy expenditure and glucose, protein and fat oxidation in severe chronic virus hepatitis B patients.

Chun-Lei Fan1, Yan-Jing Wu, Zhong-Ping Duan, Bin Zhang, Pei-Ling Dong, Hui-Guo Ding.   

Abstract

AIM: To study and determine the resting energy expenditure (REE) and oxidation rates of glucose, fat and protein in severe chronic hepatitis B patients.
METHODS: A total of 100 patients with liver diseases were categorized into three groups: 16 in the acute hepatitis group, 56 in the severe chronic hepatitis group, and 28 in the cirrhosis group. The REE and the oxidation rates of glucose, fat and protein were assessed by indirect heat measurement using the CCM-D nutritive metabolic investigation system.
RESULTS: The REE of the severe chronic hepatitis group (20.7 +/- 6.1 kcal/d per kg) was significantly lower than that of the acute hepatitis group (P = 0.014). The respiratory quotient (RQ) of the severe chronic hepatitis group (0.84 +/- 0.06) was significantly lower than that of the acute hepatitis and cirrhosis groups (P = 0.001). The glucose oxidation rate of the severe hepatitis group (39.2%) was significantly lower than that of the acute hepatitis group and the cirrhosis group (P < 0.05), while the fat oxidation rate (39.8%) in the severe hepatitis group was markedly higher than that of the other two groups (P < 0.05). With improvement of liver function, the glucose oxidation rate increased from 41.7% to 60.1%, while the fat oxidation rate decreased from 26.3% to 7.6%.
CONCLUSION: The glucose oxidation rate is significantly decreased, and a high proportion of energy is provided by fat in severe chronic hepatitis. These results warrant a large clinical trail to assess the optimal nutritive support therapy for patients with severe liver disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18666327      PMCID: PMC2731190          DOI: 10.3748/wjg.14.4365

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  10 in total

1.  Prognostic value of energy metabolism in patients with viral liver cirrhosis.

Authors:  Masahiro Tajika; Masahiko Kato; Hiromi Mohri; Yoshiyuki Miwa; Tomohiro Kato; Hiroo Ohnishi; Hisataka Moriwaki
Journal:  Nutrition       Date:  2002-03       Impact factor: 4.008

2.  Impaired insulin action despite upregulation of proximal insulin signaling: novel insights into skeletal muscle insulin resistance in liver cirrhosis.

Authors:  Niels Jessen; Esben Selmer Buhl; Ole Schmitz; Sten Lund
Journal:  J Hepatol       Date:  2006-09-28       Impact factor: 25.083

3.  Effect of late evening snack with rice ball on energy metabolism in liver cirrhosis.

Authors:  H Yamanaka-Okumura; T Nakamura; H Takeuchi; H Miyake; T Katayama; H Arai; Y Taketani; M Fujii; M Shimada; E Takeda
Journal:  Eur J Clin Nutr       Date:  2006-03-01       Impact factor: 4.016

4.  Nutritional state and energy balance in cirrhotic patients with or without hypermetabolism. Multicentre prospective study by the 'Nutritional Problems in Gastroenterology' Section of the Italian Society of Gastroenterology (SIGE).

Authors:  F W Guglielmi; C Panella; A Buda; G Budillon; L Caregaro; C Clerici; D Conte; A Federico; G Gasbarrini; A Guglielmi; C Loguercio; A Losco; D Martines; S Mazzuoli; M Merli; G Mingrone; A Morelli; G Nardone; G Zoli; A Francavilla
Journal:  Dig Liver Dis       Date:  2005-09       Impact factor: 4.088

5.  Metabolic disorders in patients with liver cirrhosis.

Authors:  Masahiko Kato; Hisataka Moriwaki
Journal:  Hepatol Res       Date:  2004-12       Impact factor: 4.288

Review 6.  Carbohydrate metabolism and the liver: actual aspects from physiology and disease.

Authors:  D Raddatz; G Ramadori
Journal:  Z Gastroenterol       Date:  2007-01       Impact factor: 2.000

7.  BCAA-enriched snack improves nutritional state of cirrhosis.

Authors:  Yutaka Nakaya; Kiwamu Okita; Kazuyuki Suzuki; Hisataka Moriwaki; Akinobu Kato; Yoshiyuki Miwa; Koichi Shiraishi; Hiroaki Okuda; Morikazu Onji; Hidenori Kanazawa; Hirohito Tsubouchi; Shinzo Kato; Masahiko Kaito; Akiharu Watanabe; Daiki Habu; Susumu Ito; Tomohisa Ishikawa; Naohiro Kawamura; Yasuyuki Arakawa
Journal:  Nutrition       Date:  2007-02       Impact factor: 4.008

8.  Clinical implications of hepatogenous diabetes in liver cirrhosis.

Authors:  Andreas Holstein; S Hinze; E Thiessen; A Plaschke; E-H Egberts
Journal:  J Gastroenterol Hepatol       Date:  2002-06       Impact factor: 4.029

9.  Weight gain after transjugular intrahepatic portosystemic shunt is associated with improvement in body composition in malnourished patients with cirrhosis and hypermetabolism.

Authors:  Mathias Plauth; Tatjana Schütz; Deborah P Buckendahl; Georg Kreymann; Matthias Pirlich; Sven Grüngreiff; Paul Romaniuk; Siegfried Ertl; Marie-Luise Weiss; Herbert Lochs
Journal:  J Hepatol       Date:  2004-02       Impact factor: 25.083

10.  GH treatment in adults with chronic liver disease: a randomized, double-blind, placebo-controlled, cross-over study.

Authors:  Jennifer D Wallace; Winsome J Abbott-Johnson; Darrell H G Crawford; Ross Barnard; Julia M Potter; Ross C Cuneo
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

  10 in total
  1 in total

1.  Effects of Tenofovir Combined with Recombinant Human Interferon α-2b on Negative Conversion Rate, Liver Function, Immune Status, and Drug Safety in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis.

Authors:  Hui Zhang; Jianchun Xian; Yang Li; Li Xiao; Lu Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-30       Impact factor: 2.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.